{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:59:53Z","timestamp":1777694393729,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T00:00:00Z","timestamp":1511740800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["14-15-00268"],"award-info":[{"award-number":["14-15-00268"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s10557-017-6762-x","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T04:08:15Z","timestamp":1511755695000},"page":"525-533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A New Class III Antiarrhythmic Drug Niferidil Prolongs Action Potentials in Guinea Pig Atrial Myocardium via Inhibition of Rapid Delayed Rectifier"],"prefix":"10.1007","volume":"31","author":[{"given":"Denis V.","family":"Abramochkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladislav S.","family":"Kuzmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid V.","family":"Rosenshtraukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,11,27]]},"reference":[{"key":"6762_CR1","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/01.CIR.101.11.1282","volume":"101","author":"S Mittal","year":"2000","unstructured":"Mittal S, Ayati S, Stein KS, et al. Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. Circulation. 2000;101:1282\u20137.","journal-title":"Circulation"},{"key":"6762_CR2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0735-1097(96)00506-2","volume":"29","author":"RH Falk","year":"1997","unstructured":"Falk RH, Pollak A, Singh SN, Friedrich T. Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. J Am Coll Cardiol. 1997;29:385\u201390.","journal-title":"J Am Coll Cardiol"},{"key":"6762_CR3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-8703(99)70363-7","volume":"137","author":"BL N\u00f8rgaard","year":"1999","unstructured":"N\u00f8rgaard BL, Wachtell K, Christensen PD, et al. Efficacy and safety of intravenously administered dofetilide in acute termination of atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled trial. Danish Dofetilide in Atrial Fibrillation and Flutter Study Group. Am Heart J. 1999;137:1062\u20139.","journal-title":"Am Heart J"},{"key":"6762_CR4","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1161\/01.CIR.102.19.2385","volume":"102","author":"S Singh","year":"2000","unstructured":"Singh S, Zoble RG, Yellen L, Brodsky MA, Feld GK, Berk M, et al. Efficacy and safety of oral dofetilide in converting to and maintaining sinus rhythm in patients with chronic atrial fibrillation or atrial flutter: the symptomatic atrial fibrillation investigative research on dofetilide (SAFIRE-D) study. Circulation. 2000;102:2385\u201390.","journal-title":"Circulation"},{"key":"6762_CR5","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1053\/euhj.1999.2039","volume":"21","author":"L Bianconi","year":"2000","unstructured":"Bianconi L, Castro A, Dinelli M, et al. Comparison of intravenously administered dofetilide versus amiodarone in the acute termination of atrial fibrillation and flutter. A multicenter, randomized, double-blind, placebo-controlled study. Eur Heart J. 2000;21:1265\u201373.","journal-title":"Eur Heart J"},{"key":"6762_CR6","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1161\/CIRCULATIONAHA.107.723866","volume":"117","author":"D Roy","year":"2008","unstructured":"Roy D, Pratt CM, Torp-Pedersen C, et al. Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial. Circulation. 2008;117:1518\u201325.","journal-title":"Circulation"},{"key":"6762_CR7","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GYH, Caterina R, et al. ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2012;33:2719\u201347.","journal-title":"Eur Heart J"},{"key":"6762_CR8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/0735-1097(96)00121-0","volume":"28","author":"KA Ellenbogen","year":"1996","unstructured":"Ellenbogen KA, Stambler BS, Wood MA, et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. J Am Coll Cardiol. 1996;28:130\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"6762_CR9","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1161\/01.CIR.94.7.1613","volume":"94","author":"BS Stambler","year":"1996","unstructured":"Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, Vanderlugt JT. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation. 1996;94:1613\u201321.","journal-title":"Circulation"},{"key":"6762_CR10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/FJC.0000000000000112","volume":"64","author":"EB Maykov","year":"2014","unstructured":"Maykov EB, Yuricheva YA, Mironov NY, et al. Efficacy of a new class III drug niferidil in cardioversion of persistent atrial fibrillation and flutter. J Cardiovasc Pharmacol. 2014;64:247\u201355.","journal-title":"J Cardiovasc Pharmacol"},{"key":"6762_CR11","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00210-015-1146-x","volume":"388","author":"DV Abramochkin","year":"2015","unstructured":"Abramochkin DV, Kuzmin VS, Rosenshtraukh LV. Effects of new class III antiarrhythmic drug niferidil on electrical activity in murine ventricular myocardium and their ionic mechanisms. Naunyn Schmiedeberg's Arch Pharmacol. 2015;388:1105\u201312.","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"6762_CR12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00424-007-0436-7","volume":"456","author":"GX Liu","year":"2008","unstructured":"Liu GX, Zhou J, Koren G. Single-channel properties of IK,slow1 and IK,slow2 in mouse ventricular myocytes. Pflugers Arch. 2008;456:541\u20137.","journal-title":"Pflugers Arch"},{"key":"6762_CR13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1113\/jphysiol.2004.063446","volume":"559","author":"J Brouillette","year":"2004","unstructured":"Brouillette J, Clark RB, Giles WR, Fiset C. Functional properties of K+ currents in adult mouse ventricular myocytes. J Physiol. 2004;559:777\u201398.","journal-title":"J Physiol"},{"key":"6762_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1085\/jgp.96.1.195","volume":"96","author":"MC Sanguinetti","year":"1990","unstructured":"Sanguinetti MC, Jurkiewicz NK. Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents. J Gen Physiol. 1990;96:195\u2013215.","journal-title":"J Gen Physiol"},{"key":"6762_CR15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF00584963","volume":"395","author":"G Isenberg","year":"1982","unstructured":"Isenberg G, Klockner U. Calcium tolerant ventricular myocytes prepared by preincubation in a \u2018KB-medium. Pflugers Arch. 1982;395:6\u201318.","journal-title":"Pflugers Arch"},{"key":"6762_CR16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0008-6363(98)00021-2","volume":"38","author":"RF Bosch","year":"1998","unstructured":"Bosch RF, Gaspo R, Busch AE, Lang HJ, Li G, Nattel S. Effects of the chromanol 293B, a selective blocker of the slow, component of the delayed rectifier K+ current, on repolarization in human and guinea pig ventricular myocytes. Cardiovasc Res. 1998;38:441\u201350.","journal-title":"Cardiovasc Res"},{"key":"6762_CR17","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0008-6363(98)00048-0","volume":"38","author":"K Eto","year":"1998","unstructured":"Eto K, Hashimoto K, Nakaya H. Preferential inhibition of IKr by MCI-154, a putative cardiotonic Ca2+ sensitizer, in guinea pig atrial cells. Cardiovasc Res. 1998;38:685\u201394.","journal-title":"Cardiovasc Res"},{"key":"6762_CR18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00005344-200007000-00011","volume":"36","author":"VV Fedorov","year":"2000","unstructured":"Fedorov VV, Sharifov OF, Beloshapko GG, Yushmanova AV, Rosenshtraukh LV. Effects of a new class III antiarrhythmic drug nibentan in a canine model of vagally mediated atrial fibrillation. J Cardiovasc Pharmacol. 2000;36:77\u201389.","journal-title":"J Cardiovasc Pharmacol"},{"key":"6762_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000016318","volume":"9","author":"S Nattel","year":"1999","unstructured":"Nattel S, Yue L, Wang Z. Cardiac ultrarapid delayed rectifiers: a novel potassium current family of functional similarity and molecular diversity. Cell Physiol Biochem. 1999;9:217\u201326.","journal-title":"Cell Physiol Biochem"},{"key":"6762_CR20","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.RES.78.4.689","volume":"78","author":"GR Li","year":"1996","unstructured":"Li GR, Feng J, Yue L, Carrier M, Nattel S. Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. Circ Res. 1996;78:689\u201396.","journal-title":"Circ Res"},{"key":"6762_CR21","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0031-6997(24)01425-X","volume":"51","author":"OE Brodde","year":"1999","unstructured":"Brodde OE, Michel MC. Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev. 1999;51:651\u201390.","journal-title":"Pharmacol Rev"},{"key":"6762_CR22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.RES.72.1.75","volume":"72","author":"NK Jurkiewicz","year":"1993","unstructured":"Jurkiewicz NK, Sanguinetti MC. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. Circ Res. 1993;72:75\u201383.","journal-title":"Circ Res"},{"key":"6762_CR23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1476-5381.2010.00897.x","volume":"161","author":"AP Larsen","year":"2010","unstructured":"Larsen AP, Bentzen BH, Grunnet M. Differential effects of Kv11.1 activators on Kv11.1a, Kv11.1b and Kv11.1a\/Kv11.1b channels. Br J Pharmacol. 2010;161:614\u201328.","journal-title":"Br J Pharmacol"},{"key":"6762_CR24","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00210-016-1265-z","volume":"389","author":"M Bebarova","year":"2016","unstructured":"Bebarova M, Matejovic P, Pasek M, Horakova Z, Hosek J, Simurdova M, et al. Effect of ethanol at clinically relevant concentrations on atrial inward rectifier potassium current sensitive to acetylcholine. Naunyn Schmiedeberg's Arch Pharmacol. 2016;389:1049\u201358.","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"6762_CR25","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.jacc.2009.12.055","volume":"55","author":"S Sossalla","year":"2010","unstructured":"Sossalla S, Kallmeyer B, Wagner S, Mazur M, Maurer U, Toischer K, et al. Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J Am Coll Cardiol. 2010;55:2330\u201342.","journal-title":"J Am Coll Cardiol"},{"key":"6762_CR26","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1161\/CIRCULATIONAHA.105.575332","volume":"112","author":"D Dobrev","year":"2005","unstructured":"Dobrev D, Friedrich A, Voigt N, Jost N, Wettwer E, Christ T, et al. The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation. Circulation. 2005;112:3697\u2013706.","journal-title":"Circulation"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10557-017-6762-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-017-6762-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-017-6762-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T14:31:55Z","timestamp":1751034715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10557-017-6762-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,27]]},"references-count":26,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["6762"],"URL":"https:\/\/doi.org\/10.1007\/s10557-017-6762-x","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,27]]}}}